Market Shockwaves from Trump's Tariff Announcement

In a move that sent shockwaves through the European pharmaceutical sector, US President Donald Trump announced plans to impose significant tariffs on pharmaceuticals. This development led to an immediate downturn in the stocks of leading European pharmaceutical companies.

Notable Declines Among Pharma Leaders

By mid-morning CET, the impact was clear. Novartis AG and Roche Holding AG saw their shares plummet by 7.03% and 5.80%, respectively. Similarly, Sanofi SA, AstraZeneca PLC, and GSK plc experienced significant drops, with shares falling by 5.64%, 6.27%, and 5.74% in quick succession.

Investor Concerns Mount

The announcement has sparked widespread concern among investors about the potential ramifications for the global pharmaceutical market. The immediate financial repercussions highlight the interconnected nature of global markets and the far-reaching impact of trade policy decisions.